New Trump administration rule aims to boost health-care price transparency
The Trump administration issued a final rule on Transparency in Coverage that adds executive attestation of price data, drawing praise from patient-advocacy groups.
The Trump administration’s Department of Health and Human Services released a final rule titled Transparency in Coverage, mandating that insurance executives attest to the truthfulness of published price data in machine-readable files. The rule also calls for reduced redundant information, more context on in-network prices, expanded out-of-network pricing details, and personalized cost-sharing info by phone. Patient-advocacy leaders, including Cynthia A. Fisher of PatientRightsAdvocate.org, praised the change as a breakthrough for compliance and a step toward lowering health-care costs.
Former Domestic Policy Council director Andrew Bremberg and OJ Oleka of the State Financial Officers Foundation echoed the sentiment, noting the rule’s capacity to empower patients and employers. Political strategist David Kochel linked the timing to upcoming midterm elections, while Save Our States’ Trent England called the policy a long-overdue common-sense reform.
Why it matters
Accurate price data could help Americans compare health-care costs and pressure insurers to lower fees.
How the sides frame it
MODERATE AGREEMENTCentrist coverage highlights the rule’s technical improvements—standardized, machine-readable data, removal of ghost rates, and cleaner spreadsheets—to help consumers compare prices, while right-leaning coverage stresses patient-advocate praise, the requirement that insurers attest to data truthfulness, and the rule’s role in empowering patients and employers.
CENTER
Centrist coverage frames the rule as a practical step toward clearer, more accessible price information for consumers.
RIGHT
Right-leaning coverage frames the rule as a breakthrough endorsed by patient-advocates that empowers patients and lowers costs.
The right emphasises
- insurance executives must attest to the truthfulness of published data
- patient-advocacy leaders praise the rule as a breakthrough
- empowers patients and employers to lower health-care costs
In this story
